Literature DB >> 18443061

Age-dependent development of chronic neuropathic pain, allodynia and sensory recovery after upper limb nerve injury in children.

Duncan D Atherton1, Omeed Taherzadeh, David Elliot, Praveen Anand.   

Abstract

Forty-nine children with distal upper limb nerve injury were studied at a mean follow-up of 2 years 3 months. Patients who were aged 5 years or younger at the time of nerve injury (15/49) had no chronic neuropathic pain symptoms or allodynia. Patients with allodynia on quantitative sensory testing but no spontaneous pain (8/49) were all older than 5 years and those reporting spontaneous chronic neuropathic pain (5/49) were all older than 12 years at the time of injury. Previous studies of adults with similar nerve injuries report chronic hyperaesthesia in up to 40% of cases. Semmes-Weinstein monofilament testing showed a positive correlation between age at injury and abnormal sensory threshold (r = 0.60, P<0.0001). These findings indicate that young children show better sensory recovery and are less likely to develop long-term chronic neuropathic pain syndromes than adults following nerve injury.

Entities:  

Mesh:

Year:  2008        PMID: 18443061     DOI: 10.1177/1753193408087029

Source DB:  PubMed          Journal:  J Hand Surg Eur Vol        ISSN: 0266-7681


  12 in total

1.  Peripheral nerve injuries in the pediatric population: a review of the literature. Part I: traumatic nerve injuries.

Authors:  Javier Robla Costales; Mariano Socolovsky; Jaime A Sánchez Lázaro; Rubén Álvarez García
Journal:  Childs Nerv Syst       Date:  2018-09-13       Impact factor: 1.475

2.  Neuropathic pain is constitutively suppressed in early life by anti-inflammatory neuroimmune regulation.

Authors:  Rebecca McKelvey; Temugin Berta; Elizabeth Old; Ru-Rong Ji; Maria Fitzgerald
Journal:  J Neurosci       Date:  2015-01-14       Impact factor: 6.167

Review 3.  Neuropathic pain in children: Special considerations.

Authors:  Gary A Walco; Robert H Dworkin; Elliot J Krane; Alyssa A LeBel; Rolf-Detlef Treede
Journal:  Mayo Clin Proc       Date:  2010-03       Impact factor: 7.616

4.  Surgical management of pediatric patients with peripheral nerve and plexus lesions caused by stray bullets.

Authors:  Fernando Guedes; Gabriel Elias Sanches; Nathalia Novaes; Amanda Guimarães Ferreira; Francisco Torrão
Journal:  Childs Nerv Syst       Date:  2020-11-03       Impact factor: 1.475

5.  The emergence of adolescent onset pain hypersensitivity following neonatal nerve injury.

Authors:  David Vega-Avelaira; Rebecca McKelvey; Gareth Hathway; Maria Fitzgerald
Journal:  Mol Pain       Date:  2012-04-24       Impact factor: 3.395

6.  Anatomical Variability Predisposed a Child to Permanent Brachial Plexopathy following Incidental Trauma.

Authors:  Banafsheh Sharif-Askary; Esperanza Mantilla-Rivas; Ishwarya Mamidi; Joseph Talbet; Monica Manrique; Marudeen Aivaz; Robert F Keating; Albert K Oh; Gary F Rogers
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-04-24

7.  The Delayed-Onset Mechanical Pain Behavior Induced by Infant Peripheral Nerve Injury Is Accompanied by Sympathetic Sprouting in the Dorsal Root Ganglion.

Authors:  Pei Liu; Qing Zhang; You-Shui Gao; Yi-Gang Huang; Junjie Gao; Chang-Qing Zhang
Journal:  Biomed Res Int       Date:  2020-06-16       Impact factor: 3.411

8.  Current concepts in diagnosis and management of common upper limb nerve injuries in children.

Authors:  Nunzio Catena; Giovanni Luigi Di Gennaro; Andrea Jester; Sergio Martínez-Alvarez; Eva Pontén; Francisco Soldado; Christina Steiger; Jiahui Choong; Paola Zarantonello; Sebastian Farr
Journal:  J Child Orthop       Date:  2021-04-19       Impact factor: 1.548

Review 9.  Nerve injury and neuropathic pain - A question of age.

Authors:  Maria Fitzgerald; Rebecca McKelvey
Journal:  Exp Neurol       Date:  2015-07-26       Impact factor: 5.330

10.  New model of vincristine-induced neuropathic pain in children: a first step towards prediction and prevention.

Authors:  Maria Fitzgerald
Journal:  Pain       Date:  2017-09       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.